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A Myc-driven self-reinforcing regulatory network
maintains mouse embryonic stem cell identity
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Stem cell identity depends on the integration of extrinsic and intrinsic signals, which directly
influence the maintenance of their epigenetic state. Although Myc transcription factors play a
major role in stem cell self-renewal and pluripotency, their integration with signalling
pathways and epigenetic regulators remains poorly defined. We addressed this point by
profiling the gene expression and epigenetic pattern in ESCs whose growth depends on
conditional Myc activity. Here we show that Myc potentiates the Wnt/b-catenin signalling
pathway, which cooperates with the transcriptional regulatory network in sustaining ESC
self-renewal. Myc activation results in the transcriptional repression of Wnt antagonists
through the direct recruitment of PRC2 on these targets. The consequent potentiation of the
autocrine Wnt/b-catenin signalling induces the transcriptional activation of the endogenous
Myc family members, which in turn activates a Myc-driven self-reinforcing circuit. Thus, our
data unravel a Myc-dependent self-propagating epigenetic memory in the maintenance of
ESC self-renewal capacity.
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During development, transient signals induce changes ingene expression pattern and chromatin structure, whichdefine cell identity and differentiation potential1,2.
Epigenetic memory plays a central role in the maintenance of
cell identity and influences cell responsiveness to environmental
cues, thus governing cell plasticity3–5. Chromatin regulators and
self-reinforcing regulatory transcription networks (TRNs) drive
the onset of epigenetic memory, which is then propagated
through stem cell self-renewal and somatic cell proliferation6.
Among them, the Polycomb (PcG) and the Trithorax (TrxG)
group of proteins are involved in the maintenance of the
repressive and active transcription states, respectively7. In
embryonic stem cells (ESCs), developmental genes are targeted
by both TrxG and PcG complexes, leading to the formation of a
permissive chromatin state characterized by the co-existence
of H3K4me3 mark embedded in H3K27me3 domains8,9.
The epigenetic state of ESCs is maintained by continuous
exposure to signals that converge on chromatin to reinforce the
self-propagating TRN3,10–13. The transcription factors Oct4, Sox2
and Nanog sustain the ES-specific gene expression programme
through an interconnected regulatory loop14. Maintenance of
ESC self-renewing state relies on exogenous stimulation with
leukemia inhibitory factor (LIF) and bone morphogenetic protein
4 (BMP4) growth factors and the consequent activation of their
downstream effectors Stat3 and Smad1, which integrate with the
core TRN by co-occupying enhancers bound by Oct4, Sox2 and
Nanog11. More recently, it has been shown that dual inhibition
(2i) of Fgf4/MEK/Erk and GSK3-b signalling pathways shields
ESCs from autocrine differentiation cues, thus stabilizing a
naı¨ve pluripotent ground state15. Of importance, the inhibition
of GSK3-b reinforces the Wnt/b-catenin signalling, which
ultimately counteracts the Tcf3 transcriptional repression
activity on the TRN16–18. The ESC dependency on LIF/Stat3
signalling could be circumvented by either inhibiting
pro-differentiation regulators15,19,20 or by enforcing expression
of pluripotency factors21–23. Among these, the Myc family
members Myc and Mycn have been described to modulate self-
renewal and pluripotency of ESCs. Functionally, the concomitant
deletion of both Myc and Mycn in pluripotent stem cells
affects self-renewal and induces cell differentiation23–26. At the
molecular level, Myc target genes are involved in cell cycle
regulation, cell growth and metabolism, thus regulating a distinct
subset of genes respect to those targeted by the core pluripotency-
associated transcription factors11,27. Importantly, Myc directly
represses genes involved in cell fate specification such as the
master regulator Gata6, through poorly defined molecular
mechanisms25. Despite the proven function of Myc in stem cell
self-renewal and pluripotency, its role in maintaining the
epigenetic state of ESCs have not been addressed so far.
Here we report a unique role of Myc in sustaining ESC identity,
which relies on the potentiation of the Wnt/b-catenin signalling
through the PRC2-dependent epigenetic silencing of Wnt
antagonists. This regulatory cascade establishes a positive
feedback loop by inducing the transcriptional activation of
the endogenous Myc and Mycn genes. Once established, this
Myc self-reinforcing circuit is sufficient to trigger an epigenetic
memory in ESCs, which in turn self renew in the absence of
further extrinsic or intrinsic signals.
Results
Myc sustains self-renewal of ESCs. To determine the functional
role of Myc on the maintenance of murine ES cells identity, we
compared ESCs grown either in LIF-containing media or in a
Myc-dependent manner (Fig. 1a). To this purpose, we took
advantage of ES MycT58AER cells (thereafter named MycER)23
expressing an exogenous MycER fusion protein activated by
4-hydroxytamoxifen (OHT). Myc-dependent ESCs (Myc), which
were maintained in the absence of LIF and in the presence of
OHT stimulation, behaved similar to the LIF grown cells with
respect to numbers of dome-shaped and alkaline phosphatase
positive (APþ ) colonies, in accordance with previously reported
data23 (Fig. 1a; Supplementary Movies 1 and 2). Similar results
were obtained both in single-cell and in long-term self-renewing
assays (Fig. 1b,c). These data suggest that MycER activation can
replace LIF signalling in the long-term maintenance of ESCs.
Considering that Myc plays a major role on cell cycle control, we
tested whether Myc ability to promote ESCs self-renewal was due
to altered cell cycle and/or proliferation in MycER cells. The cell
cycle profile, the rate of proliferation and cell division were
comparable between LIF-maintained and Myc-dependent ESCs
(Fig. 1a and Supplementary Fig. 1a,b). Accordingly, single-cell
tracking analyses show similar timing and pattern of cell divisions
of LIF- and Myc-ESCs, which are characterized by symmetric
divisions, in agreement with their self-renewing potential
(Supplementary Fig. 1b and Supplementary Movies 1 and 2).
These results suggested that perturbations of cell proliferation
and/or cell cycle progression could not account for
Myc-dependent maintenance of ESC identity. To exclude that
the above results could be ES MycT58AER clone dependent, we
generated an independent R1 ESC clone (named A2), expressing
similar level of the exogenous MycER (Supplementary Fig. 1c)
and we obtained comparable results (Supplementary Fig. 1d–f).
Taken together, these data suggest that MycER activation is
sufficient to maintain ESCs identity through a LIF-independent
regulatory circuit.
Myc activates an alternative transcription programme in ESCs.
To address the molecular mechanisms through which Myc
supports ESC identity, we performed gene expression profile
analyses of Myc- and LIF-maintained ESCs, together with epiblast
stem cell (EpiSC), as a control for a primed state of stemness.
Integrated principal component analysis (PCA) showed that
Myc-ESCs clustered together with LIF-ESCs and were distant
from both EpiSC and primordial germ cells28,29 (Fig. 1d and
Supplementary Fig. 2a). Despite these similarities, a specific gene
expression signature distinguished the Myc- from the LIF-ESCs
(Fig. 1e,f and Supplementary Fig. 2b). Ingenuity pathway analysis
(IPA) indicated that pluripotency-associated genes were enriched
among Myc upregulated genes while Nanog-correlated genes
were downregulated. This agrees with the fact that the Nanog
transcript, together with other LIF/Stat3 target genes22,30,
were downregulated in Myc- respect to LIF-ESCs (Fig. 1f,g and
Supplementary Fig. 2c). At the same time, a subset of
pluripotency transcription regulators31 including Dppa3, Utf1,
Nr0b1 and Myc were upregulated in Myc-ESCs, whereas Oct4
and Sox2 were unchanged (Fig. 1g and Supplementary Fig. 2c).
Importantly, gene set enrichment analysis (GSEA) revealed
that the Oct4/Sox2/Nanog/Tfc3 co-bound targets32 were
enriched in Myc- respect to LIF-ESCs (Fig. 1h). In addition, the
machine-learning classifier PluriTest33 highlighted a relative
enhancement of pluripotency features in Myc-ESCs (Fig. 1i).
Altogether, these multiple bioinformatic approaches indicate
that Myc potentiates pluripotency-associated genes in ESCs. In
agreement with these findings, flow cytometry analysis of Nanog
and Oct4 shows how LIF- and Myc-dependent ESCs are
homogeneous cell populations, with respect to heterogeneous
ESCs grown in the absence of LIF (-LIF; Supplementary Fig. 2d).
Finally, GSEA and functional annotation clustering showed
that signatures linked to developmental processes were
over-represented in LIF-ESCs. These findings were further
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supported by the observation that developmental genes, which are
targeted and repressed by Polycomb proteins Ring1b
(PRC1) and Eed (PRC2) were downregulated in Myc-ESCs34
(Supplementary Fig. 2e–h). In addition, genome-wide expression
profile of Eed knock-downed ESCs revealed a strong correlation
between Myc downregulated and Eed-repressed genes
(Supplementary Fig. 2i). To determine the direct contribution
of Myc in activating this alternative transcriptional programme
supporting ESC maintenance, we profiled gene expression of
ESCs grown in the presence of both LIF and OHT (LIFþ
0
–100
–50
50
100
150
PC1
PC2
0
50
100
–50
40 2060 0 –40–20 –60
PC3
–80
LIF-ESC_F
Myc-ESC_F
2i-ESC_H
EpiSC_F
EpiSC_H
Epiblast_H
PGC_H
PGCL_H
EpiLC_H
0
0
2 4 6 8 10
Log2 LIF
12 14
2
4
6
8
10
12
14
Lo
g2
 
M
yc
Socs3
Dppa3
Myc
Utf1
Mbd3
Klf4
Nanog
Oct3/4
Sox2
Myc upregulated genes
Myc downregulated genes
Term P -value
Regulation of the epithelial–mesenchymal transition pathway 4.4E–05
Human embryonic stem cell pluripotency 7.9E–05
FGF signalling 2.1E–04
Mouse embryonic stem cell pluripotency 2.5E–04
Germ cell-sertoli cell junction signalling 7.8E–04
Integrin signalling
GADD45 signalling
8.1E–04
9.8E–04
Wnt/β-catenin signalling 1.1E–03
IPA pathways
Term P -value
Role of NANOG in mammalian embryonic stem cell pluripotency 1.6E–03
Regulation of the epithelial–mesenchymal transition pathway 1.7E–02
Role of JAK1, JAK2 and TYK2 in interferon signalling 1.7E–02
JAK/Stat signalling 1.9E–02
IPA pathways
e
LIF_1
LIF_2
LIF_3
Myc_1
Myc_2
Myc_3
EpiSC_1
EpiSC_2
EpiSC_3
0.0
0.0
21.7 43.4
2.8
5.6 Z-score
0–2 2
LIF_2
Myc_1
Myc_2
Myc_3
LIF_1
LIF_3
4.64.4 4.5 4.7 4.8
0
–5
–10
–15
–20
Pl
ur
ip
ot
en
cy
 s
co
re
Novelty score
(lineage score)
d
f
b
0
10
20
30
40
LI
F
M
yc
Co
lo
ni
es
(%
 of
 to
tal
 pl
ate
d)
NS
c
0
20
40
60
80
100
P3 P6 P9
LIF
Myc
NS * *
%
 A
P-
po
sit
ive
a
LI
F
M
yc
20
40
60
80
100
0
%
 A
P-
po
sit
ive
-
LI
F
NS
*
* LIF
Myc
-LIF
Ce
ll n
um
be
r
Ce
ll n
um
be
r
Ce
ll n
um
be
r
h
g
iOct3/4-Sox2-Nanog-Tcf3 co-bound
En
ric
hm
en
t s
co
re
R
an
ke
d 
lis
t m
et
ric
 (lo
g2
 ra
tio
)
Myc
LIF
NES=1.44
P < 0.001
0.30
0.25
0.20
0.15
0.10
0.05
0.00
–0.05
–0.10
–0.15
1.0
0.5
0.0
–0.5
–1.0
0 2.500 5.000 7.500
‘LIF’ (negatively correlated)
Zero cross at 5814
‘MYC’ (positively correlated)
10.000
Rank in ordered dataset
Enrichment profile Hits Ranking metric scores
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11903 ARTICLE
NATURE COMMUNICATIONS | 7:11903 | DOI: 10.1038/ncomms11903 | www.nature.com/naturecommunications 3
Myc-ESCs) and compare it to the profiles of LIF- and Myc-ESCs.
The obtained results further confirmed that Myc supports the
transcriptional activation of pluripotency-associated genes in
ESCs (Supplementary Fig. 3a–c). Importantly, LIF-, LIFþ
Myc- and Myc-ESCs showed equivalent total RNA and mRNA
levels indicating that global transcriptional amplification35,36 did
not occurred in this setting (Supplementary Fig. 3d), as observed
upon MycER activation in proliferating fibroblasts37. Collectively,
the above data suggest that Myc supports the self-renewal of ESCs
by activating a LIF-independent alternative transcriptional
regulatory programme, reinforcing the TRN.
Myc requires Wnt/b-catenin pathway to maintain ESCs. We
next examined whether Myc could reinforce the TRN by
modulating signalling involved in pluripotency15,17,38. Both IPA
and GSEA identified the Jak/Stat3 and the MAPK pathways being
over-represented in LIF-ESCs39,40, whereas Myc potentiates the
Wnt/b-catenin signalling (Figs 1f and 2a and Supplementary
Fig. 4a and b). Importantly, the direct comparison of the gene
expression profile of LIF-, Myc- and LIFþMyc-ESCs further
confirmed that Myc drove the reinforcement of Wnt/b-catenin
signalling, whereas the LIF withdrawal caused the downregulation
of the Jak/Stat3 pathway (Supplementary Fig. 3b-c).
To understand how Myc sustains the Wnt pathway, we
first performed protein level analyses, showing that this
Myc-dependent potentiation occurred at multiple stages
(Fig. 2b). At the cell membrane level, we showed the activation
of the Fzd/Lrp receptor complex resulting in the increased
phosphorylation of Lrp6 in Myc-ESCs41. At the level of the
destruction complex, which promotes b-catenin degradation, we
registered reduction of the rate-limiting factor Axin1 and
inhibition of GSK3b41–43 (Fig. 2b and Supplementary Fig. 4c).
Interestingly, the latter could be achieved by Myc via
AKT-mediated phosphorylation of GSK3b (Fig. 2b and
Supplementary Fig. 4c). In addition, we found that the
activation of the Wnt pathway in Myc-ESC determined the
accumulation of active b-catenin (Fig. 2b) and its association
with the downstream effectors Tcf1 and Tcf3 in ESCs nuclei, as
measured by a proximity ligation assay (PLA; Fig. 2c and
Supplementary Fig. 4d,e)16,17. At the transcriptional level, we
observed that while genes coding for Wnt receptors and
co-receptors were upregulated, antagonists of the Wnt pathway,
such as the Dkk and Sfrp family members, were downregulated in
Myc-dependent ESCs, with respect to LIF-ESCs (Fig. 2d and
Supplementary Fig. 4f).
Thereafter, we determined whether the activation of the
MycER protein recapitulates the physiological role of endogenous
Myc proteins in sustaining Wnt signalling pathway in ESCs.
We transduced MycER ESCs with lentivirus expressing inducible
small hairpin RNA (shRNA) for both Myc and Mycn (i-dKD),
thus allowing us to tightly control the level and the timing of gene
silencing (Supplementary Fig. 4g). We observed that knocking
down endogenous Myc proteins results in reduced Wnt-pathway
activation, as highlighted by less active b-catenin in the
i-dKD ESCs, which is caused by the modulation of both
the responsiveness to the autocrine Wnt pathway, and the
deconstruction complex activity (Supplementary Fig. 4g).
Altogether, the obtained results indicated that Myc reinforced
the Wnt signalling pathway in ESCs.
We then investigated whether the capacity of Myc in
maintaining ESCs depends on the autocrine Wnt signalling.
We found that knocking-down b-catenin strongly affected
self-renewal of Myc-dependent ESCs, whereas it did not perturb
ESCs growth in LIF dependency (Fig. 2e and Supplementary
Fig. 4h)16,18. In addition, we showed that treating Myc-ESCs with
soluble Wnt inhibitors Dkk1 and sFRP1 induced loss of
pluripotency. Importantly, these effects were counteracted by
stimulating ESCs with soluble Wnt3a (Supplementary Fig. 4i)38.
Taken together, these data suggest that Myc exerts its function
on ESCs self-renewal by reinforcing the Wnt/b-catenin signalling
via transcriptional modulation of Wnt genes.
Myc alters the epigenetic state of bivalent genes in ESCs.
Considering that Wnt pathway-related genes are targets of both
PcG and MLL complexes in ESCs8,34,44, we asked whether their
transcriptional regulation could depend on Myc-driven epigenetic
changes at their bivalent promoters. To this end, we compared the
chromatin state between LIF and Myc-ESCs by performing
chromatin immunoprecipitation (ChIP)-sequencing experiments
using antibodies recognizing H3K4me3, H3K27me3 and the PRC2
component Suz12. Although Myc targets positively correlate with
active genes11,27, we did not measure major changes in the
genome-wide pattern of H3K4me3 (Supplementary Fig. 5a).
Rather, when we focused our analyses on bivalent genes, we
observed a redistribution of this histone mark with a relative
increased level on PRC2-low-bound genes in Myc-ESCs (Fig. 3a,e).
Genome-wide mapping of H3K27me3 showed an increased
enrichment specifically at bivalent genes promoters (Fig. 3a,e and
Supplementary Fig. 5a–c). Among the K27 gained regions, we
measured a relative enrichment at those genes, which are target of
both PRC2 and PRC1 complexes and are characterized by large
PcG domains44 (Fig. 3a and Supplementary Fig. 5c). This pattern
was mirrored by an augmented binding of Suz12 at bivalent genes
with a preferential association with PRC1 targets (Fig. 3a,e and
Supplementary Fig. 5c). Of note, we observed that some active
genes related to the Jak/Stat3 pathway gained H3K27me3, thus
Figure 1 | Myc sustains mouse ESCs identity by activating a specific transcriptional programme. (a) Alkaline phosphatase (AP) staining of murine
MycER ESCs grown for 3 days in the presence of LIF, OHT (Myc) or in -LIF conditions. Relative quantifications of positive colonies are represented as
percentage of the total colonies formed. Representative images of stained ESCs maintained for 3 days in the indicated conditions (middle panels, scale bar,
200mm) and the relative cell cycle profiles (right panels) are shown. (b) Single-cell clonogenic assay was performed and the relative number of colonies
grown in the indicated conditions was quantified and represented as percentage of the total number of single-cell plated. (c) Long-term colony-forming
assay was performed culturing cells in the presence of LIF or OHT (Myc) and the relative quantification of AP-positive colonies was assessed at the
indicated passages, until 18 days. (d) Principal component analysis (PCA) of gene expression profile of ESCs grown in the presence of either LIF (LIF-
ESC_F) or OHT (Myc-ESC_F) and EpiSC (EpiSC_F). Each sample is represented in triplicates and the analysis was integrated with previously published data
profiling the expression pattern of 2i grown ESCs, EpiLC, EpiSC, epiblasts (E5.75), primordial germ cell-like cells (PGCLCs) and primordial germ cells
(PGCs) at E9.5 (ref. 29). (e) Heat map of the most differentially expressed genes (cutoff was set to " 1.54fold change41.5, 200 genes) between LIF-ESCs
and EpiSCs. (f) Ingenuity pathway analysis (IPA) of differentially regulated genes between LIF- and Myc-dependent ESCs (n¼ 3). (g) Scatter plot of
pluripotency genes (Supplementary Data 1) expression levels, measured in LIF versus Myc-dependent ESCs (n¼ 3). (h) Gene set enrichment
analysis (GSEA) of Oct4/Sox2/Nanog/Tcf3 common target genes in Myc- versus LIF-maintained ESCs (n¼ 3). NES¼ normalized enrichment score.
(i) Machine-learning classification of gene expression pattern of LIF and Myc-dependent ESCs obtained by applying the PluriTest assay. The PluriTest
classifier assessed the pluripotency potential of the examined biological samples on the bases of their gene expression profiles. Data in panels a, b and c are
means±s.e.m. (n¼ 3). (*Po0.05; NS, not significant; Student’s t-test). See also related Supplementary Figs 1–3.
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leading to the formation of de novo bivalent genes in Myc-ESCs
(for example, Socs3 gene in Supplementary Fig. 5e). IPA indicated
that both K4 (PRC2-low) and K27/Suz12 gained regions
are enriched for Wnt pathway-related genes with the former
containing genes coding for receptors and co-receptors (for
example, Fzd7), whereas the latter being enriched for antagonists
(for example, Sfrp1; Fig. 3b,c). We then correlated modulation in
gene expression with the measured changes in chromatin features.
The obtained results showed that chromatin perturbations in
Myc-ESCs positively correlated with the transcriptional pattern of
the targets, with the up- and downregulated genes being enriched
for either H3K4me3 or H3K27me3 and Suz12 binding, respectively
(Fig. 3d and Supplementary Fig. 5d). We then determined the
direct contribution of Myc binding to the newly defined chromatin
landscape by measuring the relative enrichment of K4me3,
K27me3 and Suz12 at bivalent genes, which are directly bound
by Myc or Mycn in ESCs (Fig. 3e-f). This analysis showed that
among the Myc targets, H3K4me3 is unchanged, whereas both
K27me3 and Suz12 binding are strongly enriched, thus suggesting
a Myc-dependent modulation of PRC2 binding.
Considering the discovered role of PRC2 in controlling the
epigenetic state of Wnt pathway-related genes, we analysed
the effects of either Eed or Ezh2 knockdown on Myc-ESCs
self-renewal capacity (Fig. 3g and Supplementary Fig. 5f–i).
We observed that Myc activation, in the absence of the PRC2
complex, was not sufficient to maintain ESC self-renewal as
shown by the reduced number of dome-shaped and APþ
colonies (Fig. 3g and Supplementary Fig. 5i). Importantly, the
PRC2-dependent impairment of Myc-ESC self-renewal was
restored upon reactivation of Wnt/b-catenin signalling by
treating cells with Wnt3a (Fig. 3g and Supplementary Fig. 5i).
Collectively, the obtained results showed that Myc determines an
alternative epigenetic state at subsets of bivalent genes, which
triggers the transcriptional repression of Wnt antagonists.
Myc directly recruits PRC2 at Wnt antagonist genes. To further
determine the direct contribution of Myc to the enrichment of
H3K27me3 at Wnt antagonist genes, we investigated a possible
association between endogenous Myc and PRC2. PLAs showed
that within the cellular context, both Myc and Mycn associated
with PRC2 components Ezh2 and Eed in multiple foci
(Fig. 4a and Supplementary Fig. 6a–d). Importantly, the
specificity of the defined associations was further validated by
knocking-down either Myc transcription factors or Eed (Fig. 4a
and Supplementary Fig. 6a–d). By performing Co-IP experiments,
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we found that endogenous Myc associated with PRC2 core
complex (Eed, Suz12 and Ezh2) and the associated Aebp2
protein, but not with PRC1 core component Ring1B (Fig. 4b). We
then assessed the binding affinity and the kinetics of PRC2–Myc
protein interactions by immunoprecipitating Myc from ESC
nuclear extracts with increased salt concentrations. We observed
that the Myc–PRC2 complex is stable up to 200mM NaCl/1%
Triton, and therefore showed an intermediate binding
affinity compared with known Myc-associated proteins Tip60
and Baf53a (Supplementary Fig. 6e)27. After enriching for
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the Myc-interacting protein complexes using an affinity
chromatography purification approach, we separated the eluted
interactors by gel filtration and showed that Myc associated with
an intact and enzymatically active PRC2 complex (Supplementary
Fig. 6f–g). Mutagenesis experiments indicated that the conserved
MBII motif, located in the Myc transactivation domain
contributed in mediating the MYC–PRC2 interaction (Fig. 4c).
By using in vitro reconstituted PRC2 complex and recombinant
Myc proteins, we found that Myc interacted directly with an
enzymatically active PRC2 complex in an MBII-dependent
manner (Fig. 4d-e). By performing GST-Pull down assay
between Myc and each PRC2 components, we showed that Eed
and the cofactor Aebp2 mediated the direct association with
Myc in vitro (Supplementary Fig. 6h–i). To demonstrate the
direct interaction between Myc and PRC2 within the cellular
context, we performed acceptor photobleaching resonance energy
transfer (apFRET) assays (Supplementary Fig. 6j–k). The PRC2
proteins Eed and Aebp2 were fused with the cyan fluorescent
protein (CFP), whereas Myc wt and MycDMBII were fused to the
yellow fluorescent protein (YFP) and co-expressed in 3T3 cells.
apFRET showed that both Eed and Aebp2 interacted with
Myc, whereas their co-expression with MycDMBII resulted
in a reduction of their molecular interactions (Supplementary
Fig. 6j,k). Altogether, this set of data demonstrates the direct
interaction of both endogenous Myc and Mycn with the PRC2.
Next, we investigated the possibility that Myc could recruit
PRC2 to Wnt antagonist genes. To this end, we knocked-down
both endogenous Myc and Mycn in MycER ESCs (dKD), thus
being able to modulate Myc protein levels upon OHT treatment
(Supplementary Fig. 7a,b). The dKD ESCs behaved similar to the
control cells (shCtrl) as far as self-renewal capacity, doubling time
and cell cycle profile were concerned, whereas a prolonged
withdrawal of OHT (72 h) was not compatible with
the maintenance of self-renewal capacity (Supplementary
Fig. 7c–e)24,25. Of importance, we determined that a short
withdrawal of OHT (16 h) did not affect ESC self-renewal, thus
permitting to measure the direct effects of Myc inactivation on
chromatin states (Supplementary Fig. 7c–e). We performed ChIP
assay in ESCs in which we modulated Myc protein levels and we
found that PRC2 binding and H3K27me3 level on the promoter
of genes encoding for Wnt antagonists (Dkk1, Sfrp1, Sfrp5 and
Apccd1) were strongly reduced upon short OHT withdrawal and
rescued by MycER re-activation (Fig. 4f–h and Supplementary
Fig. 7f,g). Ring1B binding was not affected by Myc inactivation or
by its rescue, suggesting a H3K27me3-independent mechanisms
of PRC1 recruitment on these loci34,45 (Fig. 4g,h). Of note, in the
same experimental conditions, other bivalent genes (Sox17 and
Fzd1) did not show this dependence upon Myc activation
(Supplementary Fig. 7h,i). Taken together, these results indicate
that Myc, by controlling the H3K27me3 state at Wnt antagonist
genes through the recruitment of the PRC2 complex, reinforces
the autocrine Wnt signalling pathway, thereby promoting ESC
pluripotency.
Myc sustains a self-reinforcing positive feedback loop. To
identify the downstream effectors of Wnt pathway required for
Myc-ESCs maintenance, we crossed the geneset of pluripotency
factors31 with the co-bound Oct4/Sox2/Nanog and Tcf3 targets32
(Supplementary Data 1) and analysed their expression profile in
Myc- versus LIF-ESCs (Fig. 5a). We found that treatment of
Myc-ESCs with soluble Dkk1/sFRP1 inhibited the MycER-
dependent transcription activation of endogenous Myc and
Mycn, suggesting that their regulation depends on the
MycER-driven reinforcement of Wnt signalling (Fig. 5b).
Importantly, this effect was not restricted to the analysed genes
as global gene expression profiles showed that 30% of Myc-ESC
upregulated genes are downregulated in Dkk1/sFRP1-treated
cells, meaning that they are downstream of the Wnt pathway
(Fig. 5c). Moreover by ChIP assay, we found that in Myc-ESCs,
higher amount of b-catenin was associated with the Wnt
responsive element of both Myc and Mycn genes (Fig. 5d).
Thereafter, we evaluated whether endogenous Myc proteins are
required to sustain Myc-ESC self-renewal capacity. Again, we
made use of the inducible Myc and Mycn double knockdown
ESCs (i-dKD, Supplementary Fig. 4g) and we observed that the
reduction of B50% of the total amount of Myc proteins was
sufficient to block the MycER-induced self-renewing circuit in
Myc-ESCs (Fig. 5e,f). The role of endogenous Myc(s) as
downstream targets of the Wnt pathway was further illustrated
by the finding that while control ESCs responded in a
dose-dependent manner to Wnt3a-induced self-renewal, the
i-dKD cells did not (Fig. 5e,f). Taken together, these findings
showed that the activation of MycER established a positive
feedback loop by sustaining the Wnt signalling, which in turn
triggers the transcriptional activation of the endogenous Myc and
Mycn genes. This self-reinforcing circuit plays a major role in
maintaining the identity of Myc-dependent ESCs.
The Myc-driven self-reinforcing circuit maintains ESCs. We
then investigated whether the Myc-driven self-reinforcing circuit
could support the maintenance of ES cell identity in the absence
of the originating stimulus, namely the MycER activation3.
To this end, we derived ESCs from Myc-dependent cells,
following MycER inactivation upon withdrawal of OHT
(Fig. 6a) and we measured their self-renewal potential and
Figure 3 | Myc alters the epigenetic state of bivalent genes. (a) Heat maps of normalized read density of H3K4me3 and H3K27me3 deposition and Suz12
binding on bivalent genes in LIF- and Myc-dependent ESCs, ranked according to Suz12 binding in LIF-ESCs. The normalized read coverage against library
size was calculated in the distance of±10 kb to transcriptional start site (TSS) with 50 bp bin. Myc/LIF columns report TSS with read intensity fold-change
42 between Myc- and LIF-ESCs. (b) Gene ontology of bivalent genes, which gained either H3K4me3,H3K27me3 or Suz12 in Myc-ESCs, showing relative
enriched pathways. (c) Genomic snapshots showing H3K4me3, H3K27me3 and Suz12 binding in LIF- and Myc-ESCs on an antagonist (Sfrp1) and an
agonist (Fzd7) of the Wnt/b-catenin pathway. The x axis corresponds to genomic location; the y axis corresponds to ChIP-seq signal density normalized to
sequencing depth. (d) Box-and-whisker plots of the Myc/LIF gene expression fold-change of bivalent genes, which gained either H3K4me3, H3K27me3 or
Suz12 in Myc-ESCs, compared with total bivalent genes marked by H3K4me3, H3K27me3 or Suz12 binding. Boxes encompass the 25th to 75th percentiles.
Whiskers extend to 10th and 90th percentiles. The central horizontal bar indicates median fold change, the black cross indicates the mean. (e) Histograms
showing the average profile of H3K4me3, H3K27me3 and Suz12 in LIF- and Myc-ESCs, centred on TSS of total bivalent genes (up) or only the bivalent
genes, which are also Myc(s) targets (down). Window size is ±3 kb, bin size10 bp. (f) Overlap between bivalent genes, which are Myc(s) targets (Biv./
Myc target), total Suz12 targets (Suz12 total) and genes which gained Suz12 in Myc-ESCs (Suz12þ ). The P-values relative to the hypergeometric
probabilities of Biv./Myc targets, which either gained Suz12 in Myc-ESC or not are reported; total genes¼ 22,592. (g) AP staining of MycER ESCs
expressing either a control (shCtrl) or Eed (shEed) shRNA, grown 3 days in the indicated conditions; relative quantification of positive colonies is
represented as percentage of total colonies formed. Representative images are shown. Scale bar, 200mm. Data in panels d and g are means±s.e.m. (n¼ 3).
(*Po0.05, ***Po0.001; Student’s t-test). See also related Supplementary Fig. 5.
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pluripotency. We found that, despite a slight reduction in the
number of APþ colonies in the first passages, these newly
established ESCs (thereafter named Myc-derived ESCs and
indicated as -Myc in the figures) could be continuously
propagated in culture for more than 30 passages in the absence
of MycER activation and LIF stimulation (Fig. 6b). Single-cell
tracking analyses indicate that the initial reduction of colonies in
Myc-derived ESCs (-Myc) is attributable to increased cell death,
whereas their rate of proliferation, timing of division, cell
cycle profile and cell dimensions were comparable to LIF or
Myc-dependent ESCs (Fig. 6b, Supplementary Fig. 8a,b and
Supplementary Movies 3–5). In addition, the protein level of
pluripotency markers was similar among LIF-maintained,
Myc-dependent and Myc-derived cells. (Supplementary
Fig. 8c-d). Of note, the maintenance of Myc-derived ESCs was
not dependent on the culture condition used to establish them as
they could be propagated for several passages also in 2i medium
(Supplementary Fig. 8e,f). To verify that the capacity to exit
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pluripotency was not altered in Myc-derived ESCs, we finely
determined the onset of epiblast lineage commitment
(Supplementary Fig. 8e)29. The obtained results showed that the
timing of differentiation towards epiblast-like cells and the gene
expression pattern of markers of pluripotency and epiblast cells
were similar among LIF-maintained, Myc-dependent and
Myc-derived cells (Supplementary Fig. 8g,h). Importantly,
Myc-derived ESCs showed hallmarks of pluripotency and they
formed teratomas once injected in Nude mice, differentiating into
the three germ layers (Supplementary Fig. 8i–k). To assess
whether Myc-derived ESCs were endowed with naı¨ve pluripotent
potential46, we determined their capacity to form chimeric
embryos, once injected into the blastocysts. We observed that
mCherry-labelled Myc-derived ESCs contributed extensively
(53%) to the formation of developing embryos, with a high
degree of chimerism in multiple tissues, as observed at late
gestation embryonic stages (Fig. 6c). Importantly, we ascertained
that maintenance of Myc-derived ESCs was not caused by
spurious activation of MycER. Specifically, we showed that
MycER fusion protein was excluded from the nuclear
compartment in Myc-derived ESCs and it was not bound to the
chromatin of Myc targets (Supplementary Fig. 9a–c).
Accordingly, spurious activation of MycER could not account
for derivation and maintenance of Myc-derived ESCs as either
suboptimal concentration or short-term exposure to OHT
were not compatible with ESCs self-renewal (Supplementary
Fig. 9d–g). Although the Myc-derived ESCs do not rely on
MycER activation for self-renewing, we asked whether they still
depend on the downstream effectors of the self-reinforcing circuit
that has been established in the parental Myc-ESCs. We
observed that silencing of endogenous Myc and Mycn
transcripts in Myc-derived ESCs strongly affected their
self-renewal capacity and led to cell differentiation
(Supplementary Fig. 9h-i). Finally, to avoid the possibility of a
clone-dependent effect, we also obtained Myc-derived ESCs from
the independently generated R1 ESC clone A2 (Supplementary
Fig. 9j). Taken together, the above results indicated that a
prolonged activation of MycER is sufficient to establish
self-reinforcing circuits, which support the maintenance of ES
cell identity in the absence of the instructing stimulus.
Myc-derived ESCs acquire a PRC2-dependent epigenetic
memory. We then investigated whether the Myc-derived
ESCs relied on the propagation of the same transcriptional and
epigenetic programmes activated in Myc-maintained ESCs.
PCA analysis showed that the global gene expression pattern of
Myc-derived ESCs resulted similar to the parental Myc-ESCs
respect to EpiSC (Fig. 6d). Both IPA and GSEA analyses showed
that pluripotency- and Wnt pathway-related genes are reinforced
in Myc-derived relative to LIF-ESCs, whereas Jak/Stat3-related
genes are downregulated, thereby displaying a similar pattern of
signalling pathways with respect to their parental Myc-ESCs
(Fig. 6e and Supplementary Fig. 10a–c). Importantly, the
Myc-induced transcriptional programme is stably maintained as
it is preserved at late passages in Myc-derived ESCs (Fig. 6d and
Supplementary Fig. 10a–c). Given these finding we asked whether
the MycER-triggered epigenetic changes that supported the
self-reinforcing regulatory circuit in Myc-ESCs were required to
maintain Myc-derived ESCs. To verify this point, we assess the
role of PRC2 on the self-renewing capacity of Myc-derived ESCs
by using small molecules, which inhibit Ezh2 enzymatic activity
(EPZ and GSK126). The obtained results showed that PRC2
inhibition affected maintenance of Myc-derived ESCs and
H3K27me3 deposition on Wnt antagonists Dkk1 and Sfrp1
(Fig. 6f and Supplementary Fig. 10d). Importantly, exogenous
Wnt3a treatment complemented the PRC2 chemical inhibition
and restored the ability of Myc-derived cells to self-renew,
suggesting that those cells required the PRC2 complex to activate
the Wnt/b-catenin signalling (Fig. 6f). We found that in
Myc-derived ESCs the transcription levels of Wnt antagonists
Dkk1 and Sfrp1 are maintained repressed similar to Myc-ESCs,
suggesting that, despite the absence of OHT stimulation, they are
epigenetically silenced (Fig. 6g). To support this finding, we
performed ChIP assay on these targets and compared the
relative level of Suz12, Myc(s) and H3K27me3 among the
LIF-, Myc-maintained and Myc-derived ESCs. We showed that
the Wnt antagonists were repressed by the increased Suz12
binding and H3K27me3 deposition in Myc-dependent and
Myc-derived ESCs, with respect to LIF-ESC (Fig. 6h,i).
Importantly, endogenous Myc proteins bound with higher
affinity in Myc-dependent and Myc-derived ESCs, supporting the
PRC2 recruitment and H3K27me3 deposition on those loci
(Fig. 6h,i). Of note, the global level of histone modifications and
PRC2 proteins were unchanged and genomic integrity was
preserved in Myc-derived ESCs (Supplementary Fig. 10e,f).
Altogether, these data demonstrate that those epigenetic changes
that supported the self-reinforcing regulatory circuit in the
parental Myc-ESCs were maintained in Myc-derived ESCs.
To ultimately verify that the transcriptional programme of
Myc-derived ESCs was depending on epigenetic and not on
genetic changes, we attempt to revert the Myc-derived ESCs back
to a LIF-dependent state (Fig. 7a). We observed that after several
passages in LIF-conditioned medium, the Myc-derived ESCs
reverted towards a LIF-dependent state (rLIF). Reverted-LIF ESCs
formed dome-shaped and AP-positive colonies, expressing
similar levels of pluripotency and Myc(s) transcription factors
Figure 4 | Myc represses Wnt pathway antagonists via PRC2. (a) In situ proximity ligation assay between Ezh2 or Eed and Myc, in LIF-ESCs, expressing
either a control (shCtrl) or an Eed (shEed) shRNA. The proximity between Myc and an unrelated protein (IgG) was assessed as negative control. Scale bar,
50mm. (b) Nuclear extracts obtained from ESCs were either immunostained (Input) or subjected to immunoprecipitation (IP) with indicated antibodies in
the presence or absence of DNaseI. Immunostaining (IB) was performed using the indicated antibodies; 10% of the total protein samples were loaded as
input. (c) Nuclear extracts from HEK 293 cell clones expressing the Flag-Myc or the Flag-MycDMBII were used to immunoprecipitate. Myc proteins with
anti-Flag antibody and interacting proteins were revealed by immunostaining using the indicated antibodies. (d) Recombinant PRC2 complex was used to
pull-down the His-Myc wt or the His-MycDMBII recombinant proteins. The PRC2 complex was bound to the Flag-resin and the Myc protein interactions
were measured by immunostaining after peptide competition elution. (e) H3K27-histone methyltransferase activities (HMT) of the eluted protein
complexes were measured by a colorimetric assay. (f) Schematic representation of the experiment: the control (shCtrl) and the double c- and N-Myc
(dKD) ESCs were maintained, respectively, in LIF (black line) or in LIFþOHT (red line). At the indicated time point, the dKD ESCs were either grown in the
presence of OHT (þOHT, red line) or shifted to LIF only medium ("OHT, blue line) for the following 16 h. Thereafter, the MycER protein was reactivated
upon 4 h treatment with OHT (" /þ OHT, green line). (g,h) ChIP onMycER ESCs grown in the presence of LIF and expressing either a control (shCtrl) or
Myc and Mycn (dKD) shRNAs. The levels of K4me3, K27me3, Myc, Suz12 and Ring1b at the TSS of the indicated genes was measured in the control cells
(black bars), in the dKD cells maintained in the presence of OHT (red bars) or after OHTwithdrawal for 16 h (blue bars), followed by the re-induction of
MycER fusion protein by OHT treatment for additional 4 h (green bars). Data in panels g and h are means±s.d. (n¼ 3). See also related Supplementary
Figs 6 and 7.
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with respect to LIF-maintained ESCs (Fig. 7a–c). Although their
maintenance was strictly depending on the Jak/Stat3 pathway as
its brief inactivation led to cell differentiation (Fig. 7d), they
resulted insensitive to the inhibition of Wnt signalling and PRC2
enzymatic activity (Fig. 7e,f). The signalling switch from Wnt to
LIF dependency was mirrored by epigenetic changes on those
genes involved in these pathways. By ChIP assay, we found that
the modulator of Jak/Stat3 pathway Socs3, which gained de novo
H3K27me3 deposition in Myc-maintained and Myc-derived
ESCs, reacquired an active chromatin state as shown by the
increased level of H3K4me3 and the simultaneous decrease of
Suz12 and H3K27me3 at its promoter (Fig. 7g). On the contrary,
the Wnt receptor Fzd7, which was activated upon transition to
Myc-dependence state, was epigenetically repressed in rLIF-ESCs,
similar to LIF-maintained ESCs (Fig. 7g). Of note, the epigenetic
switch determined the transcriptional reactivation and repression
of these modulators of LIF and Wnt pathways, respectively
(Fig. 7h). Altogether, these results indicate that a prolonged
MycER stimulation establishes a reversible epigenetic memory in
Myc-derived ESCs, in which Wnt antagonists are maintained
repressed by endogenous Myc proteins through PRC2
recruitment. This ultimately leads to reinforcement of the
autocrine Wnt signalling pathway, which sustains maintenance
of Myc-derived ESCs.
Discussion
Self-renewing pluripotent stem cells are poised to differentiate
into any cell type in response to transient signalling cascades,
which drive the activation of downstream effectors that establish
distinct gene expression patterns that are then stably maintained.
Indeed, stem cell self-renewal and developmental transitions are
followed by dynamic changes in the chromatin state, which then
ensure the maintenance of cell identity through multiple rounds
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of cell divisions. Albeit of its importance, the molecular
mechanisms governing the transition from a temporary to a
stable and heritable gene expression programme in the absence of
the instructive signals, are largely undefined.
In this work, we report the central role of Myc in establishing
an epigenetic memory in ESCs by sustaining the self-reinforcing
TRN via the potentiation of the Wnt/b-catenin pathway and
the inhibition of autocrine Fgf4/Erk pathway, thus recapitulating
the ground state of ESCs15 (Fig. 7i). We show that the
activation of MycER establishes a positive feedback loop by
repressing the Wnt antagonists via PRC2 recruitment, thus
sustaining Wnt signalling, which triggers the transcriptional
activation of the endogenous Myc and Mycn genes. Furthermore,
we demonstrate that the Myc-driven self-reinforcing circuit
induces an epigenetic memory in ESCs, which in turns
could be propagated in the absence of further inputs from
either the ectopically expressed MycER protein or from
exogenous LIF signalling.
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Despite the proven role of Myc in the establishment and
maintenance of pluripotency23–26, its mechanisms of action are
still not fully defined. It has been proposed that Myc, by regulating
a clearly distinct set of genes from those regulated by core
pluripotency factors, participates in sustaining self-renewal by
enhancing growth, cell cycle progression and metabolisms of
ESCs11,27. Other studies proposed that Myc acts as a general
transcription amplifier by stimulating transcription elongation of
all active genes35,36. Although these activities may be important for
enhancing cellular growth and proliferation in cells overexpressing
Myc, they could not explain the crucial role of Myc in maintaining
ES cell identity. In addition, previous observation suggested that
Myc could contribute to pluripotency by directly repressing
primitive endoderm differentiation of pluripotent stem cells by
directly inhibiting the transcriptional activation of Gata6 (ref. 25).
Our results show that Myc sustains self-renewal by maintaining
repressed those genes encoding for Wnt antagonists in cooperation
with the PRC2 complex. In fact, we unveiled a critical interplay
between Myc activation and the autocrine Wnt/b-catenin
signalling which drives the onset of a positive feedback loop
through the transcriptional activation of the endogenous Myc and
Mycn genes. This regulatory circuitry stabilizes the TRN by
counteracting the transcriptional repression activity of Tcf3,
possibly through its association with b-catenin (Fig. 7i).
We demonstrated by functional analyses that the establishment
of this self-reinforcing circuit is dependent on the integrity and
biochemical activity of the PRC2. Importantly, we showed that
PRC2-dependent impairment of Myc-ESC self-renewal was
restored upon reactivation of Wnt pathway. These data highlight
the biological significance of the Myc-dependent recruitment of
the PRC2 to Wnt antagonists in ESCs. We demonstrated using
different approaches that Myc associates with PRC2 complex
through direct interaction with the core proteins Eed and Aebp2.
Interestingly, among the PcG proteins, Aebp2 is the only
transcription factor, which has been shown to have some degree
of specificity in DNA binding47. The close association of Myc
with Aebp2 within the PRC2 complex invokes the possibility of a
synergy in the DNA-binding recognition of the Myc–PRC2
complex thus favouring the selection for specific loci. In
addition, considering that Myc-dependent recruitment of the
proper cofactor to a specific target gene is crucial for the
transcriptional outcome, it is likely that a combination of events
including intracellular signalling that induce post-translational
modifications and/or the chromatin context may play an
important role in the selection of alternative complexes.
Nevertheless, although we cannot exclude other mechanisms
governing the Myc/PRC2 interplay39,48, we propose that Myc
activation drives an alternative epigenetic state in ESCs by
cooperating with PRC2 and this functional association is
instrumental for the establishment of an epigenetic memory in
the Myc-derived ESCs. Thus, our findings suggest an additional
role of PRC2 in sustaining self-renewal of Myc-dependent ESCs,
which differ from its function in lineage priming that have been
previously described34,49. The apparent discrepancy between our
findings and previous reports could be explained by considering
that the role of PRC2 in self-renewal have been evaluated in ESCs
grown in LIF-dependency34,50 or in 2i medium51 where other
signalling cascades counterbalance the improper inhibition of the
autocrine Wnt/b-catenin pathway as consequence of PRC2
inactivation. The finding that b-catenin" /" ESCs could not
self-renew in the absence of LIF stimulation16,18 support the
notion that the balance between self-renew and differentiation
potential is driven by different extrinsic and intrinsic inputs that
thereby converge on chromatin to reinforce or weaken the
self-propagating TRN. Our data indicate that alternative
regulatory circuits can be established in response to the
activation of the Wnt/b-catenin pathway and the concomitant
inhibition of Fgf4/Erk signalling, as highlighted by the different
epigenetic landscape of 2i-grown ESCs52. Distinct pluripotent
stem cells can be accomplished depending on derivation and
maintenance conditions, resulting in different epigenetic
programmes that are activated and maintained in response to
extrinsic and intrinsic signals. We here demonstrate that
exogenous Myc induces epigenetic changes, which support an
alternative pluripotent state whose maintenance depends on the
reinforcement of the Wnt pathway. However, we do not exclude
that other molecular mechanisms could be involved in inducing
or stabilizing the Myc-derived ESC epigenetic state, thereby
incrementing their self-renewal capacity and developmental
potency. Finally, our data may resolve the previous conflicting
observations showing that although Myc(s) loss is not compatible
with the maintenance of stemness in cells grown in LIF
dependency25,26, the Myc/Max complex is dispensable for
preserving ESCs when exposed to the 2i medium 15,40,52.
In summary, our data explained the molecular mechanism
through which a transient self-renewing signal, namely the
activation of MycER in ESCs, could be converted into a long-lived
epigenetic change by activating a Myc-driven positive feed-back
loop, thus establishing an epigenetic memory in ESCs.
Methods
Cell culture conditions. R1 ESCs (obtained from American Type Culture
Collection) were cultured without feeders on plastic coated with 0.1% gelatin in
DMEM supplemented with 15% FCS (Hyclone Millipore, cat. ES-009-B), 100mM
2-mercaptoethanol (Sigma, cat. M7522), 1$MEM non-essential amino
acids (Invitrogen, cat. 1140-036), 2mM L-glutamine, 1mM sodium pyruvate
(Invitrogen), 100 mgml" 1 Vitamin C (L-ascorbic acid 2-phosphatase Sigma,
A8960) and 100Uml" 1 LIF (Millipore, cat. ESG1107). The R1 MycT58AER ESCs
(clone D1) were a generous gift from Dr Stephen Dalton and were maintained in
Figure 6 | Myc-derived ESC acquired a PRC2-dependent epigenetic memory. (a) Schematic representation of the experiment. R1 MycER cells were grown
either in the presence of LIF (green line) or in the absence of LIF and in the presence of OHT (Myc, red line). Myc-ESCs were grown for six passages in
Myc-dependency (þOHT) and then were maintained in either the same culture condition (Myc) or in the absence of both OHTand LIF (Myc-derived ESCs
and indicated in figures as -Myc, orange line in panel). Alkaline phosphatase (AP) activity and gene expression profiles were analysed at indicated time
points. (b) AP staining of ESCs at indicated passages and conditions. Representative images and relative cell cycle profiles are shown. Scale bar, 200mm.
(c) Fluorescence images (right panel) of a chimeric embryo at E10.5, derived from blastocysts injected with late-passages (P16) Myc-derived ESCs carrying
a constitutively active H2B-mCherry transgene (right). A non-chimeric embryo is shown as non-fluorescent control (left). Relative bright-field images are
shown on the left; scale bar, 1mm. Lower panels show fluorescence images of organ tissues dissected from E15.5 chimeric embryos; scale bar, 100 mm (d).
Principal component analysis (PCA) of triplicate gene expression profiles of LIF-, Myc- and -Myc-ESCs at passages 9 and 16.. Expression profiles of EpiSC
are included. (e) Gene set enrichment analysis (GSEA) of Oct4/Sox2/Nanog/Tcf3 common targets (left) and Wnt pathway genes (right) in Myc-derived
at passage 9 versus LIF-maintained ESCs (n¼ 3). NES¼ normalized enrichment score. (f) AP staining of MycER ESCs grown 3 days in indicated conditions.
EPZ and GSK126 are chemicalinhibitor of the enzymatic activity of PRC2. (g) Relative transcriptional levels of indicated genes in the LIF-, Myc- or Myc-
derived ESCs (-Myc). (h,i) ChIP on MycER ESCs maintained in LIF- or Myc-dependency or the Myc-derived ESCs (-Myc). The level of H3K27me3 and the
binding of Myc, Mycn and Suz12 at the TSS of the indicated genes were measured. Data in panels b and f–i are means±s.e.m. (n¼ 3). (*Po0.05;
**Po0.01, ***Po0.001; NS, not significant; Student’s t-test). See also related Supplementary Figs 8–10.
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ESC medium as described. The R1 MycER ESCs clone A2 was obtained upon
transfection with pBABE-MycER vector followed by puromycin selection. The
double-knock down for c- and N-Myc was obtained by lentivirus transduction
followed by puromycin selection of MycER ESCs that were maintained in the
presence of 50 nM OHT (Sigma, cat. H6278) and LIF. The knock-down for Eed,
Ezh2 and b-catenin were obtained by lentivirus transduction followed by
puromycin selection of MycER ESC.
GOF18 EpiSCs were derived from E5.5 epiblasts obtained from GOF18-eGFP
mice and cultured in N2B27 medium supplemented with BSA, 0.033% Glutamax,
0.1mM b-Mercaptoethanol, 12 ngml" 1 bFGF and 20 ngml" 1 Activin-A. EpiSC
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grown on fibronectin-coated plates and splitted every 3 days 1:20 by dissociation
into small clumps with Collagenase Type IV 0.5mgml" 1 (Gibco, cat. 17104-019).
ES colony-forming assays were carried out by plating 5000 ES cells per cm2 on
0.1% gelatin-coated plates and by growing cells for 3 days. After cell fixations,
plates were stained for AP (Vector Lab., cat. SK-5100) according to the
manufacturer’s protocol and scanned with Nikon Eclipse Ti instrument to score
positive colonies. Relative quantification of positive colonies are always represented
as percentage of the total colonies formed. Single-cell colony assay was performed
by sorting viable cells into 96-well plates and plating one cell per well. Colonies
were scored on the basis of morphology and AP staining after 1 week of cell culture
in ESC medium.
EpiLCs were induced as previously described29. Briefly, ESCs maintained in 2i
medium (N2B27 medium supplemented with CHIR99021 3 mM, and PD0325901
1 mM, Sigma) were plated on fibronectin-coated plates (16.7mgml" 1) and grown
for 3 days in N2B27 medium containing Activin A (20 ngml" 1), bFGF
(12 ngml" 1) and knockout serum replacement (KSR) (1%).
All cell lines were tested by quantitative PCR to exclude mycoplasma
contamination.
Reagents. ESCs were treated with the following reagents in the described
experimental procedures: 100 ngml" 1 Dkk1 (R&D, cat. 5897-DK); 100 ngml" 1
Sfrp1 (R&D, cat. 1384-SF); 100 ngml" 1 Wnt-3a (R&D, cat. 5036-WN);
12 ngml" 1 bFGF (Invitrogen, cat. 13256029); 20 ngml" 1 Activin-A (R&D, cat.
338-AC); 3 mM CHIR99021 (AbCam, cat. ab120890); 1 mM PD 0325901
(Sigma, cat. N!PZ0162); 1 mM EPZ005687 (BioVision, cat. 2364); 2 mM GSK126
(BioVision, cat. 2282); 5 mM AG490 (Invivogen, cat. N!tlrl-ag4); 1 mM Jak1
(Millipore, cat. N!420099); 3 mM XAV939 (AbCam, cat. N!ab120897).
RNA extraction and analysis. Total RNAs were isolated from biological
triplicates of ES cell cultures after 3 days growth in indicated conditions, using
TRIzol Reagent (Ambion, cat.15596-026). Reverse transcription and PCR
amplification were performed with the Superscript III Platinum One-Step
qRT–PCR kit (Invitrogen, 11732-088) with the SYTO9 green fluorescent DNA dye
(Invitrogen, S-34854). Quantitative reverse transcription–PCR (qRT–PCR)
reactions were performed on a Rotor-Gene Q thermocycler (Qiagen, 9001560) and
relative gene expression levels were determined using calculated concentration
values, normalized to ERCC Spike-In Control RNA (Ambion, 4456740). For
microarray experiments, 500 ng of each sample of RNA were processed to generate
labelled cRNAs following the Illumina TotalPrep RNA amplification Kit (Ambion,
AMIL1791) protocol. cRNA concentration was quantified and subjected to quality
control on Agilent Bioanalyzer (Agilent Technologies, G2943CA) and hybridized
to MouseRef-8 v2 BeadChip Arrays (Illumina, 1128893).
Proximity ligation assay. ESCs were fixed in 4% paraformaldehyde (PFA) for
20min, washed, blocked and incubated with primary antibodies from different
species following the protocol procedure. PLA assay (Olink Bioscience) was per-
formed by incubating secondary antibodies conjugated with oligonucleotides
(probes) for 1 h at 37 !C followed by hybridization and ligation with the PLA probes.
Amplification of the occurred ligation was performed by in situ amplification in the
presence of fluorescent-labelled oligonucleotides. Images were acquired using Leica
TCS SP5 confocal microscope, with HCX PL APO $ 40/1.25 objective. The signal
intensity of the proximity reactions was quantified using Volocity Analysis software
(PerkinElmer).
Protein extraction, western blots, protein immunoprecipitation and protein
interactions. Total protein extracts were obtained as follows. Cells were washed
twice with cold PBS, harvested by scrapping in 1ml cold PBS and centrifuged for
5min at 1,500 r.p.m. Harvested cell pellets were lysed by the addition of 5X (v/v)
ice-cold F-buffer for 30min at 4 !C. The chromosomal binding proteins were then
separated using BioRuptor waterbath sonicator (Diagenode) at low setting for
5min. Samples were sonicated in pulse of 30 s with 30 s intervals. Lysates were
cleared by centrifugation for 10min at 14,000 r.p.m. at 4 !C and supernatant was
collected on ice. Protein concentration of lysates was determined using PierceTM
BCA Protein Assay Kit (Thermo Scientific, cat. N!23227), according to the
manufacturer’s instructions. The absorbance was measured at l¼ 595 using
SAFAS spectrophotometer (SAFAS, Monaco). Values were compared with a
standard curve obtained from the BSA dilution series.
For western blot analysis, 20 mg of protein samples were boiled and loaded onto
a pre-cast Bolt 4–12% Bis-Tris Plus gels (Novex, cat. N!NW04122BOX) and run in
Bolt MES running buffer (Novex, cat. N!B0002). After electrophoresis, proteins
were transferred to a nitrocellulose membrane. Membranes were blocked in PBS-T
containing 5% Blotting-Grade Blocker (Bio-Rad, cat. N!170-6404; blocking buffer),
for 1 h at room temperature (RT) with constant agitation and incubated with
indicated primary antibody O/N at 4 !C with agitation. The membrane was then
washed three times with PBS-T, each time for 5min, followed by incubation with
secondary antibody horseradish peroxidase-conjugated for 1 h at RT. ECL reagents
(GE Healthcare, cat. N!RPN2232) was used to initiate the chemiluminescence of
horseradish peroxidase. The chemiluminescent signal was captured using LAS3000
system (GE Healthcare). All uncropped western blots can be found in
Supplementary Fig. 11.
Nuclear proteins were extracted by incubating isolated nuclei with F-buffer
(10mM Tris-HCl at pH 7.0, 100mM NaCl, 30mM Na Pyrophosphate, 50mM
NaF, 5mM ZnCl2, 1% Triton X-100)53, briefly sonicated and treated with
10Uml" 1 DNaseI (Sigma) at 4 !C. Protein extracts were incubated with the
specific antibody and the immunocomplexes were washed four times with F-buffer
and twice with 0.15M NaCl F-Buffer. Interacting proteins were eluted by
incubating with 0.4M NaCl TE buffer. For Flag-based IP, nuclear extracts were
incubated with M2 Flag agarose resin (Sigma) overnight. Beads were washed four
times with F-buffer and twice with 0.15M NaCl F-Buffer and proteins were eluted
by incubating with 0.5mgml" 1 of 3xFlag peptide. Size exclusion chromatography
was performed on a Superose-6 10/300 GL gel filtration column (GE Healthcare) in
F-buffer using an AKTA purifier system (GE Healthcare).
ChIP assay. Each ChIP experiment was performed in at least three independent
biological samples as previously described53, with minor modifications. Briefly,
cells were crosslinked with 1% formaldehyde for 10min at RT and the reaction was
quenched by glycine at a final concentration of 0.125M, for 5min at RT. Cells were
lysed in lysis buffer (50mM Tris-HCl pH 8, 0.1% SDS, 10mM EDTA pH 8, 1mM
phenylmethyl sulphonyl fluoride (PMSF), protease inhibitor cocktail) and
chromatin was sonicated to an average size of 0.1–0.5 kb, using a Branson D250
sonifier (4 cycles of 30 s, 20% amplitude). 50 mg of each sonicated chromatin was
incubated O/N at 4 !C with 4 mg of indicated antibodies, reported in the
Supplementary Information. Protein G-coupled Dynabeads were blocked O/N at
4 !C with 1mgml" 1 sonicated salmon sperm DNA and 1mgml" 1 BSA.
Subsequently, blocked protein G-coupled Dynabeads were added to the ChIP
reactions and incubated for 4 h at 4 !C. Dynabeads linked to ChIP reactions were
then recovered and resuspended in RIPA buffer (10mM Tris-HCl, pH 8, 0.1% SDS,
1mM EDTA, pH 8, 140mM NaCl, 1% sodium deoxycholate (DOC), 1% Triton,
1mM PMSF, protease inhibitor cocktail). Magnetic beads were sequentially washed
five times with ice-cold RIPA buffer, twice with ice-cold RIPA-500 buffer (10mM
Tris-HCl, pH 8, 0.1% SDS, 1mM EDTA, pH 8, 500mM NaCl, 1% DOC, 1%
Triton, 1mM PMSF, protease inhibitor cocktail), twice with ice-cold LiCl buffer
(10mM Tris-HCl, pH 8, 0.1% SDS, 1mM EDTA, pH 8, 250mM LiCl, 0.5% DOC,
0.5% NP-40, 1mM PMSF, protease inhibitor cocktail) and once with TE buffer
(10mM Tris-HCl, pH 8, 1mM EDTA, pH 8, 1mM PMSF, protease inhibitor
cocktail). Crosslinking was then reversed in direct elution buffer (10mM Tris-HCl,
pH 8, 0.5% SDS, 5mM EDTA, pH 8, 300mM NaCl) at 65 !C O/N. Finally, DNA
was purified using SPRI beads, washed twice in EtOH 70% and dissolved in 60 ml of
Figure 7 | Myc-derived ESCs can be reverted to a LIF-dependent state. (a) Schematic representation of the experiment. R1 MycER cells were grown either
in the presence of LIF (LIF, green line) or in the absence of both LIF and OHT, after OHTwithdrawal (-Myc, orange line). These Myc-derived ESCs were either
maintained in the same culture condition (-Myc) or they were reverted back to a LIF-containing culture medium (rLIF, blue line). Alkaline phosphatase (AP)
staining was analysed at indicated time points. (b) Representative images of P staining of ESCs grown in the indicated conditions (scale bar, 200mm.
(c) Western blot analysis of pluripotency and Myc(s) transcription factors in LIF- and rLIF-ESCs. Immunostaining (IB) analysis was performed using the
indicated antibodies; b-actin was used as loading control. (d–f) AP staining to assess Jak/Stat3- (d), PRC2- (e) and Wnt-dependency (f) of LIF-, -Myc- and
rLIF-ESCs. Cells were grown in the absence (vehicle) or presence of indicated drugs (AG490 and Jaki1, EPZ and GSK126, Xav and Dkk1/sFRP1 were used to
respectively inhibit Jak/Stat3 pathway, PRC2 activity and WNTpathway). (g) ChIP on LIF-, Myc-, -Myc- and rLIF-ESCs. The levels of H3K4me3, H3K27me3
and Suz12 at the TSS of the indicated genes were measured. (h) Relative transcriptional levels of Fzd7 and Socs3 in ESCs maintained in LIF-, Myc-, -Myc- and
rLIF-ESCs, as measured by qRT–PCR analysis. Data in panels d–h are means±s.e.m. (n¼ 3). (***Po0.001; Student’s t-test). (i) Network visualization of the
Myc-mediated machinery to sustain ESCs self-renewal. The four main molecular modules are shown, from right to left: the LIF signal transduction module, the
core transcriptional regulatory network, the Wnt/b-catenin pathway and the Polycomb module. Network edges were manually curated according to literature
knowledge, laboratory findings and completed querying interaction repositories: they indicate activation (arrowheads), inhibitions (T-shaped heads) and
physical interactions (circle-shaped head). Microarray expression values (LIF/Myc ratios) of genes or RT–qPCR expression values from validation experiments
(*) are overlaid onto network depicting the LIF/Myc ratios (from green for higher LIF to red for higher Myc).
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Tris-HCl, pH 8.0. DNA was analysed by quantitative real-time PCR using SYBR
GreenER kit (Invitrogen). All experimental values were shown as percentage of
input. To take into account background signals, we subtracted the values obtained
with a non-immune serum to the relative ChIP signals. Oligonucleotide sequences
will be provided upon request.
For b-catenin ChIP experiments, cells were serially cross-linked with 2mM
Di-N-succinimidylglutarate (Sigma 80424) for 20min and 1% (v/v) formaldehyde
for 10min at RT. Crosslinking was stopped with 0.125M (v/v) glycine for 10min at
RT. 4mg of anti-bcat (200mgml" 1; Santa Cruz, sc-7199 H102) were used for each
ChIP assay.
Time-lapse video microscopy. Time-lapse video microscopy and single-cell
tracking of ESCs expressing H2B-eGFP were carried out continuously for 48 h at
37 !C and 5% CO2 using the Eclipse Ti fully automated system (Nikon). Images of
fluorescent cells were acquired every 20min with 20$ Plan Apo l objective
(Nikon) using a LED illumination system combined with a CMOS camera (Andor)
for the detection. Single-cell tracking was performed using the TTT software54 and
movies were assembled using Image J software.
Microarray analysis. BeadChip Arrays were scanned with HiScan Array Scanner
(Illumina) using the iScan Control Software (Illumina). Genes and probes
transcript levels were obtained from Illumina Intensity Data (.idat) files, applying
quantile normalization and background subtraction implemented by the
GenomeStudio Gene Expression Module v1.0 Software (Illumina). All experiments
in each condition reported were performed on triplicate biological samples, except
for the Eed knocked down ES grown in LIF withdrawal and in the presence of
OHT, for which a single replicate was analysed on the array. Cutoffs for up- and
downregulation of gene expression were set to 1.5-fold change threshold in all the
analyses performed.
Computational analysis of gene expression data. Single-microarray replicates
were subjected to dendograms cluster analysis performed with the GenomeStudio
Gene Expression Module v1.0 Software (Illumina), using Euclidean distance
matrix. The top 200 genes up- or downregulated in the comparison between LIF
maintained ES and EpiSC were selected to generate a heat-map reporting a
hierarchical clustering analysis of both genes and single-microarray replicates
(complete linkage, Euclidean distance matrix), using the TM4 MeV v4.9 software.
To perform PCA with publicly available expression profiles29, our data were
processed in the following ways. The data were corrected for background using
negative control probes based on a normal-exponential convolution and scaled
using quantile normalization and log2 transformation with R limma package.
Then, the data were batch-corrected by cell type with the published data using
ComBat. Furthermore, probes with more than twofold change in expression level
between biological replicates were excluded, and the second EpiLC replicate was
eliminated from the analysis because it is isolated from all of the other samples in
the three-principal-component space making it difficult to see the pattern depicted
in Fig. 2a. PCA was performed based on the correlation using R.
Differentially expressed genes in the LIF versus Myc maintained ES comparison
were checked for biological and functional enrichment using both IPA (Qiagen,
www.qiagen.com/ingenuity) and the Gene Ontology-based online tool PANTHER
Classification System. GSEA (http://www.broad.mit.edu/gsea/) was performed on
genesets retrieved from both public available databases (Gene Ontology and the
Kyoto Encyclopedia of Genes and Genomes, KEGG) and papers, as indicated in the
list reported in Supplementary Data 1. For GSEA, the expression data were
normalized using R limma package as described above, and the rank of genes based
on log2 ratio of classes was used to identify significant gene sets using the weighted
Kolmogorov–Smirnov test, in which phenotypes were permuted 10,000 times to
obtain stable analysis results. Furthermore, we performed the PluriTest assay33
to identify the difference between the LIF and Myc-maintained ESCs in
pluripotency-related gene expression patterns. To apply the PluriTest to our
Illumina MouseRef-8 v2 BeadChip array samples, we employed the classifier
constructed by 1,062 Affymetrix Mouse Gene 1.0 ST array samples31.
Probe identifiers of the Illumina mouse bead array were matched to those of the
Illumina human HT 12 bead array using BioMart. We followed the methods
used in ref. 3 for data normalization and the calculation of pluripotency and
lineage scores.
Network construction: a minimum set of 50 key genes belonging to
molecular modules under investigation (LIF signal transduction, core pluripotency
transcription factors, Myc, Wnt, beta-catenin and polycomb pathways) were
selected and used as input nodes to build an interaction network using Cytoscape
v.3.1.0. Manually curated interaction were added in the network annotation
according to laboratory knowledge and findings, then network were refined and
checked according to literature using the AgilentLiteratureSearch plugin and
querying interaction databases in the GeneMania framework. Once network’s
interactions were assessed, gene expression data (LIF/Myc average signal ratios
from Illumina microarrays) were overlaid to nodes and a force-directed layout was
imposed to the network. Highly clustered genes/nodes (modules) in the obtained
layout were then distributed with a circle layout for easier visualization; modules
were manually emphasized (shading and labels) using Adobe Illustrator.
ChIP-seq library generation and data analysis. Five nanograms of
immunoprecipitaded and purified DNA were used to generate ChIP-seq libraries as
previously described55, with minor modifications. Briefly, end repair of DNA
fragments was achieved by sequential 15min incubations at 12 !C and 25 !C with T4
PNK (10Uml" 1), T4 POL (3Uml" 1) and 0.1mM dNTPs. A-base addition was
performed by incubating end-repaired DNA fragments with Klenow (30-50 exo,
5Uml" 1) and 167mM dATP for 30min at 30 !C. Adaptor ligation was achieved by
using the NEB Quick ligation kit (M2200L) and perfoming an incubation of 15min
at 25 !C. Processed DNA fragments were finally amplified with a thermal cycler for
14 cycles, by using the Agilent PfuUltra II Fusion HS DNA Pol kit (600674). All
DNA purification steps between the different enzymatic reactions were performed by
using Agencourt AMPure XP SPRI beads (Beckman, A63882). The obtained libraries
were subjected to quality control on Agilent Bioanalyzer (Agilent Technologies,
G2943CA) before sequencing them with Illumina HiSeq2000. Sequenced reads were
aligned to the mouse genome (GRCm38/mm10) by using Bowtie2 version 2.2.3
(ref. 56) with default parameters; unique reads mapped to a best-matching location
with no more than two mismatches were used in the subsequent analyses. We used
MACS version 1.4.2 (ref. 57) to find the regions of ChIP-seq enrichment over
background, and all parameters were set to their defaults in the peak-calling analysis.
HOMER software58 was utilized to find peaks that are differentially enriched
between LIF-derived and Myc-derived ES cell samples with the thresholds
of42.0-fold-change ando0.001 P-value. UCSC mm10 annotation was added to all
the MACS-defined peaks and differentially enriched peaks with HOMER. TDF files
were created by using IGVTools version 2.3.26 (ref. 59) to count reads in each 25 bp
window, and the read coverage is normalized by per million mapped reads (RPM)
on IGV59. HOMER and Java Tree View60 were used to generate heat maps of ChIP-
seq enrichment around annotated transcriptional start sites (TSSs), and HOMER
and R package ggplot2 were used to create histograms of the enrichment around
TSSs. In the heat maps and histograms, the read coverage is normalized by RPM.
Recombinant protein purification and pull-down experiments. Recombinant
His-MYC and His-MYCDMBII proteins were purified as follow: bacterial pellet was
resuspended in Loading Buffer (10mM HEPES, pH 7.9, 6M guanidine and 5mM
b-mercaptoethanol) incubated for 1 h on a rocker wheel at RT and centrifuged for
30min 23,700g at 4 !C. The supernatant was loaded on His-Trap column (GE),
washed with 5 column volumes of BC500-7U (20mM Tris-HCl, pH 7.9, 7M Urea,
10% glycerol, 0.5M KCl, 5mM b-mercaptoethanol, 5mM imidazole) followed by 3
column volume washes with BC100-7U containing 30mM imidazole, and eluted
with BC100-7U containing 300mM imidazole. Fractions containing recombinant
proteins were dialysed in successive steps against BC100-4U, -2U, -1U and
finally -0U buffer, all containing 0.1% NP-40.
For the Histidine pull-down experiment, 1 mg of purified His-MYC or His-
DMBII were first bound to magnetic beads (Invitrogen) conjugated with 1 mg of
anti-Histidine antibody and then incubated with 1 mg of GST fusion proteins in
GST-binding buffer (40mM HEPES, pH 7.3, 200mM KCl, 0.1% Nonidet P-40,
0.2% Tween-20, 5mM b-mercaptoethanol, inibitor protease cocktail) for 2 h at
4 !C. After extensive washes in the same buffer, the interacting proteins were eluted
by heating the samples at 95 !C and analysed by immunoblotting.
DNA constructs. The Flag-MYC and Flag-MYCDMBII constructs have been
previously described53. Myc, Mycn, b-catenin, Eed and Ezh2 Dkk1 and Sfrp1
shRNA constructs were obtained from Open Biosystem (TRCN0000042515,
TRCN0000020694, TRCN0000012690 TRCN0000095722 and TRCN0000039042,
respectively). The inducible IPTG-driven shRNA for Myc and Mycn were
custom-made from Sigma-Aldrich (MISSION 3xLacO inducible shRNA system).
For pull-down assay, the cDNAs corresponding to the human open reading frame
of AEBP2, EED, EZH2, RBBP4, RBBP7 and SUZ12 were cloned into the bacterial
expression vector pGEX-4T. To obtain the expression of the full-length EZH2
protein, the 3X FLAG tag was subcloned at the 30 end of EZH2 cDNA. For FRET
assay, EED and AEBP2 were cloned in pECFP-N1 or pEYFP-N1 (Clontech)
vectors, positioning the fluorescence tags at C-termini, whereas NLS-, EZH2, MYC
and MYCDMBII were cloned into YFP-containing pcDNA5/FRT (Invitrogen)
vector positioning the fluorescence tags at N-termini.
Flow cytometry analysis (FACS). Intracellular FACS quantification of Oct4 and
Nanog protein levels was performed as previously described12 with minor
modifications. Briefly, cells were dissociated with 0.25% trypsin and fixed first in
0.25% PFA in ES medium then in 70% methanol in PBS for 1 h at 4 !C. Cells were
permeabilized and blocked in PBS/BSA 1%/Triton X-100 0.1%/goat serum10%
(GIBCO Life Technologies, cat. no 16210-064) for 30min at RT. The staining was
performed overnight at 4 !C in the same buffer containing the indicated antibodies:
anti-Oct4 (Santa Cruz, cat. no sc-5279) and anti-Nanog (Bethyl, cat. no
A300-397A) to a final concentration of 2.5 and 10 mgml" 1, respectively. For the
detection anti-mouse IgG-Alexa Fluor-647 (Invitrogen, cat. no A21236) and
anti-rabbit IgG-Alexa Fluor-405 (Invitrogen, cat. no. A31556) were used for Oct4
and Nanog, respectively (1/200 for 2 h at RT).
For cell cycle analysis, trypsinized cells were washed with PBS, and cell nuclei
DNA were stained with propidium iodide overnight using the DNA con 3 kit
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(Consul T.S.) and samples were analysed using the FACS Canto II
(Becton&Dickinson).
Immunostaining. Immunofluorescence experiments were performed on 4%
PFA-fixed cells grown on fibronectin-coated coverslips using standard procedures.
Images were acquired using a Leica TCS SP5 confocal microscope with HCX PL
APO $ 40/1.25 objective. The presented images are the maximal projections of the
five central stacks of the total z-axis range acquired (between 12 and 18 mm, each
stack was 0.5 mm size).
Fluorescence resonance energy transfer (FRET). NIH3T3 cells were transfected
with the appropriate ratio between the fluorescence-tagged proteins to optimize
protein distribution. MYC-interaction experiments were performed by co-expressing
the MAX protein (MYC: MAX ratio 4:1) and the protein of interest. FRET acceptor
photobleaching was carried out using the Leica TCS SP2 confocal microscope and
apFRET software (Leica) according to the manufacturer’s instructions. Fixed cells
were analysed with a HCX PL APO lbd.BL 63.0$ 1.40 oil objective and $ 8 zoom.
The argon laser was tuned to 458 nm to excite CFP (PMT window 465–495 nm) and
to 514 nm to excite YFP (PMT window 555–630 nm). The region of interest was
bleached until intensity of 20% in the YFP channel using the 514 argon laser line.
Teratoma assay. Teratoma formation was assessed by injecting intracranial ESCs
(Lif, Myc, - Myc) in 7-week-old immuno-compromised female mice (CD1 nude).
Briefly, 2$ 105 cells suspended in 2 ml of DMEM were delivered into the right
striatum by stereotactic injection. The following coordinates were used:
antero-posterior¼ 0; mediolateral¼ 2.5mm; dorso-ventral¼ 3mm. Mice were
killed at different times from 2 to 4 weeks post injection, according to the cell line
originally injected. Haematoxylin and eosin staining was performed on 5-mm-thick
paraffin sections.
Generation and analysis of chimeric mice. We generated Myc-derived ESCs and
labelled them with H2B-mCherry recombinant protein. Myc-derived labelled ESCs
were injected into morula stage of C57BL/6N embryos and reimplanted into
8-week-old pseudopregnant C57BL/6N female mice (Charles River Italia). Whole
embryos at E10.5 and E15.5 were recovered and analysed for the mCherry signal by
fluorescence microscopy. We evaluate the efficiency of Myc-derived ESCs to
contribute to chimaerism by calculating the percentage of mCherry-labelled
embryos out of all embryo obtained from injected morula (8/15).
Karyotype assay. To perform the karyotype assay, ESCs at exponential growth
phase were cultured in the presence of colcemid (0.1mgml" 1) for 8 h. Cells were
rinsed with PBS, trypsinized for 5min and pelleted by centrifugation. Pellets were
resuspended in 500 ml of hypotonic solution (0.56% KCl) dropwise and incubated
at RT for 15min. We then collected the cells by 2min spinning at 2,000 r.p.m. and
resuspended the pellet gently in cold methanol/acetic acid (3:1) fixative. Fixed ESC
suspension was dropped onto microscope slide and chromosome spreads were
visualized with 4,6-diamidino-2-phenylindole.
Antibodies. The antibodies used in this work are purchased by Santa Cruz
Biotechnology (anti-MYC sc-764 for immunoprecipitation assay, ChIP
experiments and immunoblotting; anti-N-MYC sc-56729; anti-MAX sc-197 and
sc-765; anti-E-Cadherin sc-7870; anti-Oct3/4 sc-5279; anti-GST sc-138; anti-His
sc-8036; anti-Tle3 sc-9124; anti-Tle4 sc-365406; anti-Tcf-3 sc-8635; anti-ERa
sc-544), by Millipore (anti-histone H3 06-755; anti-trimethyl histone H3 Lys4
07-473; anti-trimethyl histone H3 Lys27 07-449; anti-Eed 05-1320; anti-Ezh2
07-689), by Cell Signalling (anti-Suz12 D39F6; anti-Ezh2 AC22; Phospho-GSK-3b
(Ser9) 9323; anti-GSK-3b 9315; anti Lrp6 3395; anti-Ph-Lrp6 2568; anti-
Phospho-Akt (Ser473) 4060; anti-Phospho-Akt (Thr308) 2965; anti-Akt 2920;
anti-Erk1/2 9102; anti-Ph-Erk1/2 4370; anti-Active b-catenin, 8814; anti-Axin1
2087; anti-Tcf1 2203) by Abcam (anti-Myc ab11917 for MycER immunoblotting;
anti-Suz12 ab12073; anti-Aebp2 ab101655; anti-Utf1 ab24273) and by Bethyl
laboratories (anti-Menin A300-105A; anti Ash2l A300-112A; anti-Rbbp5
A300-109A; anti-Nanog A300-397A), by BD Trasduction Laborotories
(anti-b-catenin 610153); from Zymed anti-Lamin B1 33-2000; from R&D
(anti-Sox2 AF2018; anti-Klf4 3158) and anti-Ring1B was provided by Dr Haruhiko
Koseki (RIKEN Yokohama Institute, Japan).
Ethical statement. Animals have been housed in the animal house at Hospital San
Raffaele (HSR—Milan). The use of animals has followed the ethical guidelines by
IACUC 681 approved by HSR internal committee and Italian Ministry of Health
and according to the national laws.
Statistical analysis. All the quantitative data are shown as means plus s.e.m. or
s.d., as specified in each figure legend. No statistical method was used to
predetermine sample size and all experiments were repeated at least three times
with specific sample sizes reported in each figure legend. Data collection was
conducted randomly. Statistical P values calculated by unpaired Student’s t-test are
indicated in figures and relative figure legends (where not differentially specified,
*Po0.05, **Po0.01, ***Po0.001). P values o0.05 were considered significant.
Data collection and analysis of all studies involving animals were conducted
randomly but not blinding.
Data availability. The Microarray and ChIP-seq data that support the findings of
this study have been deposited in the NCBI Gene Expression Omnibus database
under accession code GSE80558.
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